secwatch.observer — SEC 8-K summary
======================================

Issuer:     MAIA Biotechnology, Inc. (MAIA)
CIK:        0001878313
Form:       8-K
Filed at:   2025-12-17T23:59:59+00:00
Accession:  0001493152-25-028041
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MAIA Biotechnology announces $1.51M private placement of common stock and warrants
--------------------------------------------------------------------------------

- Gross proceeds ~$1.51M from 1,233,488 shares at $1.224 each, with warrants exercisable at $1.36.
- Warrants exercisable six months after issuance, three-year term, priced at NYSE American minimum price.
- Directors subscribe for 179,737 shares (~$220k); Louie Ngar Yee, Stan Smith, Steven Chaouki.
- Net proceeds to fund Step 1 of Part C of Phase II THIO-101 trial and working capital.
- Expected close Dec 18, 2025; securities unregistered, offered under Section 4(a)(2)/Reg D.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1878313/000149315225028041/0001493152-25-028041-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1878313/000149315225028041/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-028041

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer